To add, "IF" HEB gets FDA approval for Ampligen, although the flu and FDA approval for CFS have nothing to do with each other, this will help out sales for flu because it is very tough to get approval by the FDA for safety reasons alone. Some other countries may not even test, or if they do, do a very short study on the safety of Ampligen because the FDA already approved it and that will be enough or very close to enough for other countries to go on.
FDA approval for Ampligen is big in so many ways. If we get approval HEB will have an even more severe problem. They will not be able to produce nearly enough Ampligen, and even if they partner, they better partner with many because production for CFS and global flu will be tough to keep up with.